Search

everythinglearnresearchcommunity

for

Search:↓

Short-chain fatty acids from *Cutibacterium acnes* cause skin inflammation, contributing to acne.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Extracts from Tridax procumbens L. have strong anti-inflammatory and antioxidant effects and block inflammation-causing enzymes.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Targeting Hedgehog signaling may help treat ligamentum flavum fibrosis.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Nonanal from fruits and vegetables promotes hair growth by increasing growth factors.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

A comprehensive, personalized approach is needed for treating female pattern hair loss and obesity, involving multiple medical disciplines and lifestyle changes.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

New therapies like JAK inhibitors, PRP, and stem cell treatments show promise for better alopecia management.

Scalp psoriasis is treated with topical therapies, phototherapy, and systemic medications.

Upadacitinib may effectively treat alopecia areata without side effects.

Baricitinib successfully treated severe hair loss.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.